BroadOak Logo

Latest News

Updates on BroadOak investments, transactions, events, and industry news.
Aalto Bio Reagents Logo

BroadOak Partners advised Aalto Bio Reagents on the sale of the company to Biosynth Carbosynth, a

BroadOak Logo

BroadOak’s Q1 Quarterly Review analyzes market trends and M&A transactions across life science tools, diagnostics, and

BIOLOG logo

BroadOak is pleased to announce its investment in Biolog, a leading provider of cell-based microbial identification

BroadOak portfolio company Reaction Biology Corporation was acquired by Cobepa. Reaction Biology is a leading contract

Genomenon logo

BroadOak increased its investment in Genomenon, a company that organizes the world’s genomic data. The full

BroadOak Logo

BroadOak’s Q4 Quarterly Review analyzes market trends and M&A deals across life sciences tools, diagnostics, and

Rockland logo

Rockland Immunochemicals, Inc. acquired antibodies-online in a transaction financed by BroadOak Capital Partners. Bill Snider, Partner

FlowMetric logo

KCAS Acquires FlowMetric

BroadOak Partners advised KCAS, a Vitruvian Partners portfolio company, on the acquisition of FlowMetric, LLC. FlowMetric

MyChem logo

BroadOak Partners advises MyChem, LLC on the sale of the company to Maravai LIfeSciences (NASDAQ: MRVI).

It is an exciting time at BroadOak as we help advance innovative life sciences technologies.

Holly Atallah
Director of Finance & Operations

BroadOak Logo Only

Our Story

BroadOak has advised and invested in life sciences companies for over 15 years. Get to know us.